Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03345771 · ClinicalTrials.gov registry record · Phase 3
Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty
A Phase 3 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 230
- Enrollment target
NCT03345771 is a Phase 3 study that has completed, run by NYU Langone Health. The registered enrollment target is 230 participants.
The verdict
NCT03345771, a Phase 3 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 230 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing or portable negative pressure wound dressing is superior in preventing wound complications and infection rates in obese patients undergoing total joint arthroplasty (TJA). Approximately 240 subjects (120 for total knee arthroplasty and 120 for total hip arthroplasty) will be enrolled to evaluate the outcomes associated with silver impregnated dressings and negative pressure wound therapy (NPWT) in treating this subset of patients and analyze the cost benefit of each.
Interventions
- COMBINATION_PRODUCT Antimicrobial Barrier Dressing
- DEVICE Negative Pressure Wound Therapy (NPWT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2021-06-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03345771
The ClinicalTrials.gov registry entry for NCT03345771 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Antimicrobial Barrier Dressing is the first listed.
NCT03345771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03345771 about?
NCT03345771 is a clinical study titled "Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty". The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing or portable negative pressure wound dressing is superior in preventing wound complications and infection rates in obese patients undergoing total joint arthroplasty (TJA). Approximately 240 subjects (120 fo...
What is the current status of trial NCT03345771?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 230 participants. The study started on 2017-11-13. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03345771?
The interventions under investigation include: Antimicrobial Barrier Dressing (COMBINATION_PRODUCT), Negative Pressure Wound Therapy (NPWT) (DEVICE).
Who is sponsoring clinical trial NCT03345771?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.